$TZYM Ocera Therapeutics, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Ocera Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Ocera Therapeutics, Inc. Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
14159 capital (GP), LLC | 10% Owner | 57,704 | 0 | Mar 14 2012 | |||
ABERCROMBIE GEORGE B | Director | 0 | 0 | Oct 20 2011 | |||
ABERCROMBIE GEORGE B | Director | 0 | 0 | Aug 09 2012 | |||
Aggarwal Gaurav | Chief Business Officer | 20,000 | 0 | Jan 19 2016 | |||
Aggarwal Gaurav | Chief Business Officer | 0 | 0 | Jun 13 2014 | |||
Baker Biotech Capital (GP), LLC | 10% Owner | 232,011 | 0 | Mar 14 2012 | |||
Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 3,540,015 | 0 | Mar 14 2012 | |||
BDC CAPITAL INC. | 10% Owner | 2,238,825 | 0 | Apr 06 2011 | |||
BLAIR JAMES C | 10% Owner | 1,897,336 | 0 | Jul 16 2013 | |||
Bukofzer Stan | Chief Medical Officer | 0 | 0 | Dec 11 2017 | |||
Byrnes Michael | CFO and Treasurer | 0 | 0 | Dec 11 2017 | |||
Capital regional et cooperatif Desjardins | 10% Owner | 1,262,022 | 0 | Apr 07 2011 | |||
Castaigne Jean-Paul | Director | 0 | 0 | Apr 21 2011 | |||
Castaigne Jean-Paul | Director | 0 | 0 | Aug 09 2012 | |||
Castaigne Jean-Paul | Director | 0 | 0 | Jun 13 2014 | |||
Davidson Aaron | Director | 0 | 0 | Apr 21 2011 | |||
Davidson Aaron | Director | 0 | 0 | Aug 09 2012 | |||
Dere Willard H | Director | 0 | 0 | Dec 11 2017 | |||
DOMAIN ASSOCIATES | 10% Owner | 0 | 0 | Dec 13 2017 | |||
Domain Partners VI, L.P. | 10% Owner | 0 | 0 | Dec 13 2017 | |||
Domain Partners VIII, L.P. | 10% Owner | 0 | 0 | Dec 13 2017 | |||
DOVEY BRIAN H | 10% Owner | 1,897,336 | 0 | Jul 16 2013 | |||
DP VI Associates, L.P. | 10% Owner | 0 | 0 | Dec 13 2017 | |||
DP VIII Associates, L.P. | 10% Owner | 0 | 0 | Dec 13 2017 | |||
Eisenstadt Richard I | VP, Finance & C.F.O. | 0 | 0 | Apr 21 2011 | |||
Eisenstadt Richard I | VP, Finance & CFO | 0 | 0 | Aug 09 2012 | |||
Garg Vipin K | President & C.E.O. | 0 | 0 | Apr 21 2011 | |||
Garg Vipin K | President & CEO | 0 | 0 | Aug 09 2012 | |||
Gavin Brenda D | Director | 0 | 0 | Apr 21 2011 | |||
Grais Linda S | President and CEO | 0 | 0 | Dec 11 2017 | |||
Grais Linda S | President and CEO | 0 | 0 | Jul 17 2013 | |||
Grais Linda S | President and CEO | 10,000 | 0 | Jul 15 2014 | |||
H.I.G. Ventures - Tranzyme, LLC | 10% Owner | 3,002,291 | 0 | Apr 06 2011 | |||
Halak Brian K | 10% Owner | 1,897,336 | 0 | Jul 16 2013 | |||
HILLEMAN JERYL L | CFO and Secretary | 0 | 0 | Dec 23 2013 | |||
JAMES STEVEN P | Director | 0 | 0 | Dec 11 2017 | |||
James Steven P | Director | 0 | 0 | Sep 18 2014 | |||
JOHNSON JOHN | Director | 0 | 0 | Apr 21 2011 | |||
JOHNSON JOHN | Director | 0 | 0 | Aug 09 2012 | |||
Kjellson Nina S | Director | 0 | 0 | Dec 11 2017 | |||
Kjellson Nina S | Director | 0 | 0 | Jun 13 2014 | |||
Kjellson Nina S | Director | 1,248,064 | 0 | Nov 12 2013 | |||
Kjellson Nina S | Director | 825,826 | 0 | Jul 17 2013 | |||
Kosutic Gordana | VP, Clinical and Regulatory | 0 | 0 | Apr 21 2011 | |||
McGowan Dana S. | CFO and Secretary | 0 | 0 | Jul 16 2013 | |||
Moore David | VP, Commercial Operations | 1,050 | 0 | Oct 04 2011 | |||
Moore David | VP, Commercial Operations | 0 | 0 | Apr 23 2012 | |||
Patni Rajiv | Chief Development Officer | 5,050 | 0 | May 07 2015 | |||
POWELL MICHAEL | Director | 705,368 | 0 | Dec 30 2016 | |||
POWELL MICHAEL | Director | 9,364 | 0 | Mar 20 2014 | |||
POWELL MICHAEL | Director | 0 | 0 | Jun 13 2014 | |||
QUAKER BIO VENTURES LP | 10% Owner | 2,564,791 | 0 | Apr 06 2011 | |||
ROUSSEAU FRANCK | Chief Medical Officer | 0 | 0 | Oct 21 2011 | |||
ROUSSEAU FRANCK | Chief Medical Officer | 0 | 0 | Aug 09 2012 | |||
ROUSSEAU FRANCK | Chief Medical & DEV Officer | 0 | 0 | Dec 23 2013 | |||
SCHOEMAKER KATHLEEN K | 10% Owner | 1,897,336 | 0 | Jul 16 2013 | |||
Shah Pratik | Director | 0 | 0 | Dec 23 2013 | |||
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 9,364 | 0 | Mar 20 2014 | |||
TETLOW SHARON | Acting CFO & Treasurer | 3,000 | 0 | Jul 15 2014 | |||
Thomas Helmut | Senior VP, R&D | 0 | 0 | Apr 21 2011 | |||
Thomas Helmut | Senior VP, R&D | 0 | 0 | Aug 09 2012 | |||
THOMAS MCNERNEY & PARTNERS LP | 10% Owner | 3,002,286 | 0 | Apr 06 2011 | |||
TREU JESSE I | 10% Owner | 1,897,336 | 0 | Jul 16 2013 | |||
VANLENT ANNE | Director | 0 | 0 | Dec 11 2017 | |||
VANLENT ANNE | Director | 0 | 0 | Apr 21 2011 | |||
VANLENT ANNE | Director | 0 | 0 | Aug 09 2012 | |||
VANLENT ANNE | Director | 0 | 0 | Jun 13 2014 | |||
VITULLO NICOLE | 10% Owner | 1,897,336 | 0 | Jul 16 2013 | |||
WEBER ECKARD | Director | 0 | 0 | Dec 11 2017 | |||
WEBER ECKARD | Director | 344,719 | 0 | Jul 16 2013 | |||
WEBER ECKARD | Director | 0 | 0 | Jun 20 2014 | |||
WIERENGA WENDALL | Director | 0 | 0 | Jun 13 2014 | |||
WIERENGA WENDALL D | Director | 0 | 0 | Dec 11 2017 | |||
Zisson Alex | Director | 0 | 0 | Apr 21 2011 | |||
Zisson Alex | Director | 0 | 0 | Aug 09 2012 |